skeleton
• most mice develop increasing cranial perimeter or cranial deformity
|
cellular
• increase in proliferation of leptomeningeal pigmented melanocytes
|
behavior/neurological
• symptoms progress rapidly to akathisia and general malaise
|
• at a median age of 4 months
|
• mice exhibit incoordination at a median age of 4 months
|
• mice show impaired gait at a median age of 4 months
|
mortality/aging
• mice die before 12 months of age
|
craniofacial
• most mice develop increasing cranial perimeter or cranial deformity
|
integument
• mice develop benign paucicellular dermal melanocytic lesions resembling human blue nevi
|
pigmentation
• increase in proliferation of leptomeningeal pigmented melanocytes
|
• brains show darkening of the leptomeninges that follows the sulci and fissures, and is more prominent in the frontoparietal region
• increase in the number of pigmented melanocytes that follow the gyri and sulci and envelop the ventricles (melanocytosis)
|
• hyperpigmented dendritic melanocytes are seen in 3 week old and adult mice, particularly between the collagen bundles of the reticular dermis and along the adnexae of the deep dermal layers
|
• darkening of the skin, tails, paws, and snouts that is evident from day 1 and persists throughout life
|
neoplasm
• darkly pigmented areas in the brain are composed of large melanocytic lesions comprising pleomorphic cells that invade the brain parenchyma with tumor cells rapidly dividing, indicating primary melanoma of the central nervous system
• however, mice do not develop cutaneous melanoma or tumors in the uvea, hearts, or oral and genital mucosa
• tumor cells frequently present intracytoplasmic melanin
|